MANIFOLD
Will China's FDA grant approval to an mRNA COVID vaccine by the end of 2022?
29
Ṁ495Ṁ6.1k
resolved Jan 1
Resolved
NO

Resolves YES if China approves a COVID vaccine based on mRNA technology by the end of 2022. Resolves NO if not.

Market context
Global Macro
China
Medicine
COVID
Get
Ṁ1,000
to start trading!

🏅 Top traders

#TraderTotal profit
1Ṁ105
2Ṁ91
3Ṁ33
4Ṁ21
5Ṁ19
Sort by:
predictedYES

This market seems wrongly priced given today's China moves out of Zero-COVID policies. Moreover: https://scrip.pharmaintelligence.informa.com/SC147467/China-Set-To-Green-Light-First-mRNA-Vaccine

Arb'ed based on the logic that it is impossible for this market to have a higher probability than the same market, resolving at the end of 2023.

People are also trading

Will FDA approve more than 10 new mRNA based vaccines before 2028?
42% chance
Will FDA approve more than 10 new mRNA based vaccines before 2030?
67% chance
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
21% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
45% chance
Will FDA approve any mRNA vaccine against AIDS before 2028?
24% chance
Will FDA approve any mRNA vaccine against glioblastoma before 2028?
20% chance
Will FDA approve any type of personalized cancer mRNA vaccines before 2028?
42% chance
Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
41% chance
Will FDA approve any mRNA vaccine against any strain of influenza before 2028?
78% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
© Manifold Markets, Inc.•Terms•Privacy